Koukourikis Periklis, Alqahtani Ali Abdullah, Han Woong Kyu, Rha Koon Ho
Department of Urology, Urological Science Institute Yonsei University College of Medicine Seoul South Korea.
Second Department of Urology, School of Medicine Aristotle University of Thessaloniki Thessaloniki Greece.
BJUI Compass. 2022 Jan 12;3(3):251-256. doi: 10.1002/bco2.131. eCollection 2022 May.
To assess the feasibility and safety of pure single-port (SP) retzius-sparing robot-assisted radical prostatectomy (RARP) using the da Vinci SP and describe the technique.
From August 2020 to November 2020, data of 10 consecutive patients with localized prostate cancer, who underwent SP retzius-sparing RARP, were prospectively collected. Patients demographics, intraoperative variables, postoperative complications, early oncological, and functional outcomes were assessed.
The patients were aged 46-73 years with a body mass index between 20.3 and 27.4 kg/m. Prostate volumes ranged from 15 to 47.2 ml, with a median (interquartile range, IQR) PSA level of 7.4 (6.2-9.1) ng/ml. All surgeries were successfully completed without conversion. The median (IQR) operative and console time were 106 (101-109) min and 65 (63-68) min, respectively. The median (IQR) blood loss was 125 (50-150) ml, and one Clavien-Dindo grade I complication occurred. At 3 months, nine patients had undetectable PSA levels and all patients were continent.
Pure SP retzius-sparing RARP could be safely performed using the da Vinci SP system, with acceptable surgical times and minimal complications. Future research will evaluate the advantages of this technique over the standard multiport robotic surgery.
评估使用达芬奇单孔手术系统进行单纯单孔保留Retzius间隙机器人辅助根治性前列腺切除术（RARP）的可行性和安全性，并描述该技术。
前瞻性收集了2020年8月至2020年11月连续10例接受单孔保留Retzius间隙RARP的局限性前列腺癌患者的数据。评估患者的人口统计学特征、术中变量、术后并发症、早期肿瘤学和功能结果。
患者年龄46 - 73岁，体重指数在20.3至27.4kg/m之间。前列腺体积为15至47.2ml，前列腺特异性抗原（PSA）水平中位数（四分位间距，IQR）为7.4（6.2 - 9.1）ng/ml。所有手术均成功完成，无中转情况。手术时间中位数（IQR）为106（101 - 109）分钟，控制台操作时间中位数（IQR）为65（63 - 68）分钟。失血中位数（IQR）为125（50 - 150）ml，发生1例Clavien-Dindo I级并发症。3个月时，9例患者PSA水平检测不到，所有患者均无尿失禁。
使用达芬奇单孔手术系统可安全地进行单纯单孔保留Retzius间隙RARP，手术时间可接受，并发症极少。未来研究将评估该技术相对于标准多孔机器人手术的优势。
